The protein family containing the α,β-hydrolase fold is one of the largest and most diverse protein families, covering most, albeit not all, serine hydrolases. The α,β-hydrolase fold family includes lipases, esterases, epoxidases, peroxide hydrolases, and dehalogenases.^[@ref1],[@ref2]^ A subgroup of the the α,β-hydrolase family consists of 22 members sharing the ABHD (α/β hydrolase fold domain) nomenclature. They generally have a GXSXG motif, and conserved structural features shared by this subfamily predict common roles in lipid biosynthesis and metabolism.^[@ref3]^

Deregulated lipid metabolism is the underlying cause of many human disorders.^[@ref4],[@ref5]^ In line with this, ABHD11 is deleted in the Williams-Beuren syndrome,^[@ref6]^ and mutations in ABHD12 have been shown to be causative in polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC).^[@ref7]^ The α,β-hydrolase domain-containing protein 2 (ABHD2) is essential in hepatitis B virus propagation^[@ref8]^ and is associated with chronic diseases that involve monocyte/macrophage recruitment, such as emphysema and atherosclerosis.^[@ref9]−[@ref11]^ ABHD2 has been identified as a progesterone (P~4~)-dependent 2-arachidonoylglycerol (2-AG) hydrolase.^[@ref12]^ 2-AG is an endogenous inhibitor of the CatSper channel in spermatozoa. Upon progesterone stimulation, ABHD2 hydrolyzes 2-AG, leading to a CatSper opening that triggers sperm hyperactivation and makes spermatozoa fertile. Despite the potentially important role of ABHD2 during various (patho)physiological processes, such as virus propagation, atherosclerosis, and fertilization, selective small molecule inhibitors are currently not available to study the biological role of this enzyme in an acute setting.

Activity-based protein profiling is a valuable technology to rapidly identify novel inhibitors. It makes use of activity-based probes (ABPs) that assess the functional state of enzymes in complex proteomes.^[@ref13]−[@ref15]^ We have previously shown that the β-lactone-based ABPs MB064 and MB108 target a broad range of serine hydrolases and can be used for inhibitor discovery and profiling.^[@ref16]−[@ref18]^ Here, we describe the target scope of MB064 and MB108 and map the activity of ABHD2 in eight different mouse tissues. Next, we tested 200+ lipase-directed inhibitors on ABHD2 and related ABHD-proteins in a *library-versus-library* screen. Such a screen facilitated the rapid identification of selective inhibitors for ABHD2, which reduced the acrosome reaction in mouse spermatozoa.

Results {#sec2}
=======

Identification of α,β-Hydrolase Fold-Containing Proteins Targeted by MB064 and MB108 {#sec2.1}
------------------------------------------------------------------------------------

Previously, a large variety in expression for α,β-hydrolase fold family members across different tissue types has been observed by *in situ* hybridization and in global proteomics studies.^[@ref3],[@ref13],[@ref19],[@ref20]^ Therefore, it was investigated whether this tissue-specific expression was mirrored by enzyme activity as measured by MB064. The labeling profile of MB064 in the mouse cytosol and membrane fractions of the brain, heart, kidney, liver, lung, pancreas, spleen, and testis revealed a highly diverse labeling pattern across different tissue types ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B). To determine the identity of the proteins, a tissue-wide chemoproteomic screen was performed by using MB108, a biotinylated analog of MB064 ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A).^[@ref16]^ As a reference for probe targets, a list of α,β-hydrolase fold enzymes was retrieved from the ESTHER database (<http://bioweb.ensam.inra.fr/esther>).^[@ref21]^ A phylogenetic tree of 136 α,β-hydrolase fold containing enzymes was generated using multiple sequence alignment (Muscle) and ClustalW2 omega phylogeny ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C).^[@ref22]^ The α,β-hydrolase fold-containing proteins detected in this chemoproteomic screen are highlighted in red. The screen revealed that 66 out of the 136 known mouse α,β-hydrolase fold proteins, including ABHD2, were detected by MB108 in one or more tissues. In addition, a number of hydrolases and transferases that did not contain the α,β-hydrolase fold motif, but had a catalytic nucleophile that can attack the β-lactone, were also targeted ([SI Figure 1](http://pubs.acs.org/doi/suppl/10.1021/acschembio.9b00640/suppl_file/cb9b00640_si_001.pdf)). Interestingly, ABHD2 activity was most abundant in testis followed by kidney and liver.

![Detection of α,β-hydrolase fold enzyme activity in the mouse brain proteome, by using β-lactone-based ABPs MB064 and MB108. (A) Chemoproteomic screen of α,β-hydrolase fold enzyme activity in the mouse proteome, by using β-lactone-based activity-based probe MB108 (10 μM). Mean of the average spectral counts over three replicate experiments. Heatmap: proteins are ordered by hierarchical clustering. Intensities in blue represent the relative activity per protein in each tissue. Intensities in orange are the spectral counts in the tissue where the protein shows highest activity. (B) In-gel fluorescence readout of mouse tissues labeled by ABP MB064 (2 μM) in the membrane and cytosolic mouse proteomes. (C) Phylogenetic tree of α,β-hydrolase fold proteins generated by multiple sequence alignment (Muscle) and ClustalW2 omega phylogeny. Proteins highlighted in red are targeted by MB108. All proteins are serine hydrolases except those in bold or highlighted in blue. Blue proteins lack a catalytic triad. Bold proteins have a cysteine or asparagine as a catalytic residue. Gray dots indicate organophosphate-targeted proteins.](cb9b00640_0001){#fig1}

![(A) Phylogenetic tree of the α,β-hydrolase fold family members sharing the ABHD nomenclature. The tree is generated by multiple sequence alignment (Muscle) and ClustalW2 omega phylogeny. Proteins used for the inhibitor screen are highlighted in red. (B) Labeling of ABHD proteins overexpressed in HEK293T or U2OS cells. Protein labeling of ABHD transfected cells was compared to mock transfected cells in the membrane (M) and cytosolic (C) fractions. Proteins (1 mg mL^--1^) were labeled by ABP MB064 (2 μM). Overexpressed proteins are marked by a red triangle. (C) Anti-FLAG Western blot for confirmation of protein expression and localization of the transfected ABHD. Cutout at the molecular weight indicated by the red triangle is represented. Full gels and blot are given in [SI Figures 2 and 3](#notes-3){ref-type="notes"}.](cb9b00640_0002){#fig2}

It is well-known that α,β-hydrolase fold proteins react well with organophosphates.^[@ref23]^ Therefore, organophosphate-based ABPs are widely applied tools to study α,β-hydrolase fold protein enzymatic activity.^[@ref24]^ For example, Bachovchin and colleagues have previously targeted \>80% of mammalian metabolic serine hydrolases by using a single fluorophosphonate (FP)-based ABP.^[@ref13]^ To study whether β-lactone-probe targets are complementary to proteins that are known to interact with organophospates, the FP-probe targets are marked with a gray dot in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C. A large overlap between the targets of organophosphates and MB108 was observed. Of note, MB108 targeted DAGLα, FAM135, FAM135B, CES5A, and ABHD14A, which were not detected in studies with organophosphate-based probes.^[@ref13],[@ref23]^ In conclusion, the β-lactone-based ABPs, MB064, and MB108 are powerful broad-spectrum tools to study the ABHD2 activity and detect many members of the α,β-hydrolase fold family (∼50%), including several members that were not detected by organophosphate-based probes.^[@ref13],[@ref23]^

Gel-Based Screen to Identify Novel Inhibitors for ABHD Family Members {#sec2.2}
---------------------------------------------------------------------

To identify selective ABHD2 inhibitors, a competitive screen between ABHD proteins and a targeted lipase inhibitor library with 207 members ([Supporting Table 2](http://pubs.acs.org/doi/suppl/10.1021/acschembio.9b00640/suppl_file/cb9b00640_si_002.xlsx)) was made. Chemoproteomic ABPP is highly sensitive and allows one to study native enzymes with relatively low abundance and activity in tissues or cells. However, chemoproteomics is expensive and time-consuming, and thus it is not suitable for high-throughput screening of inhibitor libraries. Therefore, a gel-based assay using MB064 was employed to identify novel inhibitors for ABHD2 and its family members. It is still sometimes challenging to correlate enzymes to specific fluorescent bands on SDS-PAGE in native proteomes, and native enzymes may show large variations in labeling intensities, due to unequal tissue distribution. Thus, to avoid these limitations we expressed recombinant proteins to generate protein libraries for inhibitor screening.

The human enzymes sharing the ABHD nomenclature corresponding to the enzymes that were detected in the chemoproteomic mouse tissue screen (ABHDs 3, 4, 6, 11, 12, and 16A) were recombinantly expressed in HEK293T ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A). The constructs were equipped with a FLAG-tag to monitor protein expression and gel migration. Instead, ABHD2 was expressed in U2OS cells because the efficiency of expression of its construct in HEK293T cells was too low. No expression or labeling of ABHD10, 14A, 14B, and 16B in HEK293T nor U2OS could be achieved for as yet unclear reasons ([SI Figures 1, 2](http://pubs.acs.org/doi/suppl/10.1021/acschembio.9b00640/suppl_file/cb9b00640_si_001.pdf)). Labeling with MB064 (2 μM) of lysates from ABHD transfected cells compared to mock transfected cells was used to monitor protein activity. To establish a multiple protein assay, recombinantly expressed proteins were pooled in protein libraries. ABHD3, 4, and 12 clustered around a molecular weight of ∼40 kDa. Therefore, two protein libraries were required to resolve all expressed ABHDs using 1D SDS-PAGE. Protein library 1 contained ABHD2, 3, and 12, and protein library 2 consisted of ABHD4, 6, 11, and 16A ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A,B).

![(A) Fluorescent labeling (MB064, 2 μM) of HEK293T/and or U2OS lysates that overexpress ABHD4, 6, 11, 16A and DAGL-α, and a combination thereof to form protein library 1. (B) Fluorescent labeling (MB064, 2 μM) of HEK293T lysates that overexpress ABHD12, 3, 2 and a combination thereof to form protein library 2. (C) Graphical representation of the number of hits per chemotype per enzyme. (D) Heatmap overview of the inhibitor screen.](cb9b00640_0003){#fig3}

The lipase-focused inhibitor library contained 207 compounds that can be divided in 3 major classes (α-ketoamides, β-ketoamides, and 1,2,4-triazole ureas), and a set of unique chemotypes (singletons). Screening of the compound library at a concentration of 10 μM against the 2 protein libraries generated ∼1500 protein--inhibitor interaction data points and revealed that all proteins were hit by one or more compounds ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C,D). Inhibitors were qualified as a hit when protein labeling was reduced \>70% compared to the vehicle-treated control. A clear distinction between target profiles of different inhibitor classes was detected ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C). The α-ketoamides were inactive against all tested ABHD family members. The β-ketoamides provided an excellent chemotype to inhibit ABHD3: 21 hits were identified, 13 of which were considered selective (\<50% inhibition of the other ABHDs). Compounds **47** and **60** were the most potent ABHD3 inhibitors that remained selective over the other measured ABHDs. Inhibitors from the 1,2,4-triazole-urea class were more reactive. This class effectively targeted ABHD6 and ABHD11 (\>70% of the compounds were classified as hits). No selective inhibitors were found for ABHD4, 6, 11, 12, or 16A, yet the nonselective compounds may still represent interesting starting points for hit optimization programs. Compound **183** and **184** from the singletons reduced the labeling of ABHD2 by \>70% without reducing the labeling of other ABHD's by \>50%. In a concentration--response experiment, a modest pIC~50~ of 5.50 ± 0.06 was determined for **183** ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A,B). The structurally related compound **184**, with a pyrrolidine moiety, had a 10-fold lower activity (pIC~50~ of 4.60 ± 0.10).

![Structure--activity relationships of lead inhibitors for ABHD. (A) Dose-dependent effect of 183 and 184 on ABHD2 labeling by MB064 (2 μM) on gel. (B) Dose--response curve of inhibitor **183** (pIC~50~ = 5.50 ± 0.06) and **184** (pIC~50~ = 4.60 ± 0.10).](cb9b00640_0004){#fig4}

Inhibitor Selectivity {#sec2.3}
---------------------

To investigate the selectivity of inhibitor **183** in more detail in a native mouse proteome, competitive ABPP with broad-spectrum FP-based serine hydrolase probes (FP-TAMRA and FP-biotin) and the ABPs MB064 and MB108 was employed.^[@ref17]^ The fluorophosphonate was added to broaden the scope of the selectivity profile.^[@ref13]^ Because of the important role in sperm fertility and the high expression of ABHD2 in the testis, the selectivity of ABHD2 inhibitor **183** (20 μM, 30 min) was investigated in the mouse testis proteome using MB064 and TAMRA-FP ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}A,C). Inhibitor **183** reduced labeling of one fluorescent band in the cytosolic proteome, as determined by FP-TAMRA. The competitive chemoproteomic assay confirmed ABHD2 inhibition, with no other targets being detected ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}B,D). Together, these studies indicate that inhibitor **183** shows a highly restrictive off-target profile and can be used to inhibit ABHD2 in the testis proteome in an acute fashion.

![Chemoproteomic assay for ABHD2 selectivity in mouse testis. (A) Gel-based competitive ABPP with inhibitor **183** (2 and 20 μM) and MAFP (2 μM) against TAMRA-FP (2 μM) in the mouse testis cytosolic and membrane fractions. (\* indicates a band reduced in **183** treated vs control.) (B) Competitive chemoproteomic selectivity assay of inhibitor **183** (20 μM) in the testis proteome using ABP FP-biotin (10 μM). (C) Gel-based competitive ABPP with inhibitor **183** (2 and 20 μM) and MAFP (2 μM) against MB064 (2 μM) in the mouse testis cytosolic and membrane fractions. (D) Competitive chemoproteomic selectivity assay of inhibitor **183** (20 μM) in the mouse testis proteome using ABP MB108 (10 μM).](cb9b00640_0005){#fig5}

Compound **183** Reduces Acrosome Reaction and Inhibits ABHD2 Activity *in Vitro* {#sec2.4}
---------------------------------------------------------------------------------

The acrosome reaction (AR) is a crucial process that enables capacitated spermatozoa to fertilize mammalian eggs.^[@ref25],[@ref26]^ AR precedes sperm penetration through the zona pellucida and fusion with the oocyte membrane. This process is calcium-dependent, and it is induced in mammals in capacitated spermatozoa through the stimulation by several molecules, including the steroid hormone progesterone (P~4~).^[@ref12],[@ref27]^ Intracellular calcium elevation triggers the fusion between the sperm plasma membrane and the outer acrosomal membrane. In order to monitor the dynamic of such a key event, Peanut Agglutinin-Fluorescein isothiocyanate (PNA-FITC) that selectively binds to the sugar residues present in the acrosome of spermatozoa has been used. Therefore, PNA-FITC staining allowed one to distinguish sperm with intact acrosome ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}A) from AR ones.^[@ref28]^

![(A) Representative image of one acrosome intact and one AR spermatozoa with the acrosomal enzymatic content and the nuclei stained with the PNA-FITC (green fluorescence) and DAPI (blue fluorescence), respectively. (B) Incidence of AR recorded on *in vitro* capacitated spermatozoa exposed to progesterone (P4:3 μM) in the absence (Ctrl) or presence of increasing concentrations of MAFP and **183** (from 0.2 nM to 2 μM). The induction of AR promoted by P~4~ was prevented in spermatozoa treated with 2 μM of MAFP or **183**. In order to exclude any toxic effect, *in vitro* capacitated spermatozoa were also incubated with 2 μM of both the inhibitors (MAFP and 183 groups) without any treatment of P~4~. Data are expressed as mean with SD of *n* = 3 independent experiments. One-way ANOVA followed by post hoc Tukey's multiple comparisons test. (C) Intracellular calcium analysis. Stimulation with P~4~ increases intracellular calcium levels in mouse spermatozoa as measured using Fluo-3 AM. **183** (2 μM) blocks the rise in intracellular calcium levels 5, 10, and 15 min after P4 stimulation. The data are expressed as florescence arbitrary units (Arb. Units) and are the mean ± standard deviation of three independent samples (full time course and positive control with ionomycin is given in [SI Figure S9](http://pubs.acs.org/doi/suppl/10.1021/acschembio.9b00640/suppl_file/cb9b00640_si_001.pdf)). \**P* \< 0.05, \*\**P* \< 0.01, \*\*\*\**P* \< 0.0001](cb9b00640_0006){#fig6}

In vitro capacitated spermatozoa exposed to P~4~ (3 μM) significantly increased the incidence of AR (from approximately 20% to 35%). ABHD2 inhibitor **183** reduced P~4~-induced AR in a concentration-dependent manner ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}B). The broad spectrum serine hydrolase inhibitor MAFP that was used as a positive control exerted similar inhibitory action.^[@ref12]^ Next, intracellular calcium measurements in mouse sperm were performed. Treatment with **183** (2 μM) blocks the calcium increase induced by P~4~, indicating a role of ABHD2 in the regulation of intracellular calcium levels in mouse sperm ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}C). To further corroborate these functional data, ABHD2 was overexpressed in U2OS cells, and its activity was measured *in vitro* by a monoacylglycerol-lipase ABHD2 activity assay. Of note, ABHD2 activity was found to be enhanced by P~4~, and to be reduced by MAFP (used as a positive control)^[@ref12]^ and dose-dependently by **183** ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}).

![(A) Representative image of U2OS cells transfected with ABHD2-GFP (green) plasmid. (B) Effect of progesterone (P~4~) on ABHD2 *in vitro* activity, when added directly to the culture medium alone or in the presence of MAFP and **183**. Data are expressed as mean with SD of *n* = 3 independent experiments. \**p* \< 0.05 and \*\*\**p* \< 0.001.](cb9b00640_0007){#fig7}

Discussion {#sec3}
==========

The target profile of the β-lactone containing ABPs (MB108 and MB064) across the mouse proteome (spleen, pancreas, liver, testis, brain, kidney, heart, and lung) was mapped. The ABPs interacted with ABHD2 and almost 50% of the α,β-hydrolase fold superfamily, including FAM135A, FAM135B, ABHD14B, and CES5A, which were not previously detected by organophosphates.^[@ref13],[@ref23]^ The broad interaction landscape of the β-lactone-containing ABPs enabled the parallel screening of a targeted serine hydrolase inhibitor library for ABHD2 and multiple other ABHD enzymes. This led to the rapid identification of compound **183** as a novel inhibitor for ABHD2.

Recently, ABHD2 was shown to be highly expressed in spermatozoa, to bind P~4~, and to act as a P~4~-dependent 2-AG hydrolase.^[@ref12]^ It finely tunes endogenous inhibition of the sperm calcium channel (Catsper) by 2-AG. Indeed, depletion of 2-AG by the hydrolytic activity of ABHD2 enables calcium influx via Catsper, leading to sperm activation in humans. A previous report indicated that murine Catsper is insensitive to P~4~, and may therefore lack regulation by ABHD2.^[@ref29]^ Differential localization of ABHD2 in murine (restricted to the acrosomal region) compared to human (acrosomal region and flagellum) spermatozoa may explain the lack of murine Catsper regulation by P~4~, while still exhibiting a P~4~-induced acrosome reaction.^[@ref12]^ The percentage of murine P~4~-stimulated acrosome reacted spermatozoa was reduced by the newly identified ABHD2 inhibitor **183**. In addition, we have shown that the P~4~ induced calcium increase in mouse spermatozoa is blocked by the inhibition of ABHD2 using **183**. A different calcium channel from Catsper could be involved in a ABHD2 regulated calcium flux in mouse sperm. Further research is required to identify the molecular components that constitute the pathway downstream of ABHD2 that regulates the acrosome reaction in mouse spermatozoa. Of note, the previously used inhibitor MAFP^[@ref12]^ is known to target numerous endocannabinoid hydrolases, including fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), and ABHD6,^[@ref30]^ whereas the ABHD2 inhibitor **183** displayed a highly restricted off-target profile in the mouse testis. Therefore, here we have provided further support to the key-role of ABHD2 in the P~4~-stimulated acrosome reaction. On this basis, **183** seems to represent an excellent starting point for further optimization of ABHD2 inhibitors that can modulate sperm fertility by preventing a sperm--egg recognition mechanism and may lead to a novel formulation of contraceptives. On a final note, it should be noted that the cross-talk between P4 and the ABHD2-dependent endocannabinoid metabolism appears to be of broad interest, and clearly extends previous data on the ability of P~4~ and strictly related steroid hormones to control other elements of endocannabinoid signaling, like the anandamide-hydrolase FAAH,^[@ref31],[@ref32]^ and the endocannabinoid-binding CB~1~ receptors.^[@ref33]^ Overall, this cross-talk brings about an unprecedented type of regulation, whereby 2-AG signaling is continuously "on" (to block Catsper), unless P~4~ terminates it by stimulating 2-AG hydrolysis by ABHD2.^[@ref12]^ Therefore, the widely accepted dogma of the "on demand" synthesis of 2-AG, that suggests that this compound acts only upon stimulus-dependent release from phospholipid precursors, might not hold true in all tissues, extending previous observations on anandamide (AEA).^[@ref34]^

Experimental Methods {#sec4}
====================

Cell Culture {#sec4.1}
------------

Cell culture was performed as described previously.^[@ref17]^ In brief, HEK293T or U2OS cells were grown in DMEM with stable glutamine and phenol red (PAA), 10% newborn calf serum, penicillin, and streptomycin. Cell passage was performed every 2--3 days by resuspension in medium and seeding to appropriate confluence.

Transfection and Cell Lysis {#sec4.2}
---------------------------

24 h prior to transfection, 10^7^ cells were seeded in a 15 cm Petri dish. A 3:1 mixture of polyethylenimine (60 μg) and plasmid DNA (20 μg) in 2 mL serum free medium was added. The medium was refreshed after 24 h, and after 72 h, HEK293T (48 h for U2OS) cells were harvested in 20 mL medium. Cells were isolated by centrifugation for 10 min at 1000 rpm and subsequent aspiration of the medium. The cell pellet was flash-frozen in liquid nitrogen and stored at −80 °C until use.

Cell pellets were slowly thawed on ice and suspended in lysis buffer (20 mM HEPES pH 7.2, 2 mM DTT, 0.25 M sucrose, 1 mM MgCl~2~, 25 U/mL Benzonase). Three pulses with a polytrone (3 × 7 s) were used to homogenize the suspension. After homogenization, the suspension was allowed to incubate for 10 min on ice. Ultracentrifugation (100,000 × g, 45 min, 4 °C, Beckman Coulter, Type Ti70 rotor) was used to separate the cytosolic and membrane fractions. The pellet (membrane fraction) was suspended in storage buffer (20 mM HEPES pH 7.2, 2 mM DTT). The total protein concentration was determined with Quick Start Bradford assay (Biorad) or Qubit protein assay (Invitrogen). The lysates were flash-frozen in liquid nitrogen and stored at −80 °C until use.

Preparation of Mouse Tissue Proteome {#sec4.3}
------------------------------------

Mouse tissue was isolated according to guidelines approved by the ethical committee of Leiden University (DEC\#13191). Mouse tissues were dounce homogenized in pH 7.2 lysis buffer A (20 mM HEPES pH 7.2, 2 mM DTT, 1 mM MgCl~2~, 25 U/mL Benzonase) and incubated for 5 min on ice. The suspension was centrifuged (2500 × g, 3 min, 4 °C) to remove debris. The supernatant was collected and subjected to ultracentrifugation (100,000 × g, 45 min, 4 °C, Beckman Coulter, Type Ti70 rotor). This yielded the membrane fraction as a pellet and the cytosolic fraction in the supernatant. The membrane fraction was suspended in a storage buffer (20 mM HEPES pH 7.2, 2 mM DTT). The total protein concentration was determined with a Quick Start Bradford assay (Biorad) or Qubit protein assay (Invitrogen). Membranes and supernatant were flash-frozen in liquid nitrogen and stored in aliquots at −80 °C until use.

Gel-Based Tissue Screen (MB064) {#sec4.4}
-------------------------------

The membrane or lysate fraction of mouse brain, heart, kidney, liver, lung, pancreas, spleen, or testis was diluted to 1 mg mL^--1^. Proteome (1 mg mL^--1^, 20 μL) was incubated at 37 °C for 15 min with MB064 (1 μM, final concentration). After 15 min the reactions were quenched with 10 μL standard 3 × SDS-PAGE sample buffer. The samples were directly loaded and resolved on SDS PAGE gel (10% acrylamide). The gels were scanned using a ChemiDoc MP system (Cy3 settings, 605/50 filter) and analyzed using Image lab 4.1.

Chemoproteomic Tissue Screen {#sec4.5}
----------------------------

The membrane or lysate fraction of mouse brain, heart, kidney, liver, lung, pancreas, spleen, or testis was diluted to 2 mg mL^--1^. The proteomes (490 μL) were incubated with 10 μL of 500 μM ABP MB108 (final concentration 10 μM) for 1 h at rt. The labeling reaction was quenched, and excess probe was removed by chloroform methanol precipitation. Precipitated proteome was suspended in 500 μL 6 M urea/25 mM ammonium bicarbonate and allowed to incubate for 15 min. 5 μL of 1 M DTT was added, and the mixture was heated to 65 °C for 15 min. The sample was allowed to cool to rt before 40 μL (0.5 M) iodoacetamide was added, and the sample was alkylated for 30 min in the dark. 140 μL 10% (wt/vol) SDS was added and the proteome was heated for 5 min at 65 °C. The sample was diluted with 6 mL PBS. 100 μL of 50% slurry of Avidin--Agarose from egg white (Sigma-Aldrich) was washed with PBS and added to the proteome sample. The beads were incubated with the proteome for 3 h.

Beads were isolated by centrifugation and washed with 0.5% (wt/vol) SDS and PBS (3×). The proteins were digested overnight with sequencing grade trypsin (Promega) in 100 μL Pd buffer (100 mM Tris Ph 7.0, 100 mM NaCl, 1 mM CaCl~2~, 2% ACN, and 500 ng trypsin) at 37 °C with vigorous shaking. The pH was adjusted with formic acid to pH 3 and the beads were removed. The samples were further purified and measured as described previously.^[@ref16]^

Enzyme Mixes for Inhibitor Screen {#sec4.6}
---------------------------------

Protein library 1 is made in standard assay buffer (20 mM HEPES pH 7.2, 2 mM DTT) and contains the following transiently transfected proteins (concentrations are final concentrations): 4 mg mL^--1^ cytosolic fraction of ABHD12 transfected HEK293T cell lysate, 0.3 mg mL^--1^ membrane fraction ABHD3 transfected HEK293T cell lysate, and 1 mg mL^--1^ membrane fraction of ABHD2 transfected U2OS cell lysate.

Protein library 2 is made in standard assay buffer (20 mM HEPES pH 7.2, 2 mM DTT) and contains the following transiently transfected proteins (concentrations are final concentrations): 1 mg mL^--1^ cytosolic fraction of ABHD4 transfected HEK293T cell lysate, 0.25 mg mL^--1^ membrane fraction ABHD6 and 11 transfected HEK293T cell lysate, 0.2 mg mL^--1^ membrane fraction ABHD16A transfected HEK293T cell lysate, and finally 0.5 mg mL^--1^ membrane fraction DAGL-α transfected HEK293T cell lysate.

Inhibitor Screen {#sec4.7}
----------------

Enzyme mix 1 or 2 (19.5 μL) was incubated with DMSO (0.5 μL) or inhibitor (0.5 μL, 400 μM; 10 μM final concentration) for 30 min at 37 °C. Next, MB064 (0.5 μL, 80 μM; 2 μM final concentration) was incubated for 15 min at 37 °C. The reactions were quenched with 10 μL standard 3×SDS PAGE sample buffer. The samples were directly loaded and resolved on SDS PAGE gel (10% acrylamide). The gels were scanned using a ChemiDoc MP system (Cy3 settings, 605/50 filter), and the percentage inhibition was determined by comparison with DMSO (100%) using Image Lab 4.1. Control for protein loading was performed by Coomassie staining and adjustment for total lane intensity.

Gel-Based Dose--Response Analysis {#sec4.8}
---------------------------------

Dose response analysis was performed as described previously.^[@ref16]^ In brief, transfected proteome (19.5 μL) was incubated with DMSO (0.5 μL) or inhibitor (0.5 μL) at the indicated final concentrations for 30 min at 37 °C. Next, MB064 (0.5 μL, 80 μM; 2 μM final concentration) was incubated for 15 min at 37 °C. The reactions were quenched with 10 μL standard 3×SDS PAGE sample buffer. The samples were directly loaded and resolved on SDS PAGE gel (10% acrylamide). The gels were scanned using a ChemiDoc MP system (Cy3 settings, 605/50 filter); the percentage of activity remaining was determined by measuring the integrated optical intensity of the fluorescent protein bands using Image Lab 4.1. The relative intensity was compared to the vehicle treated proteins, which were set to 100%. Correction for protein loading was performed by Coomassie staining. IC~50~ values were determined by plotting log(inhibitor) vs normalized response (variable slope); dose--response curve was generated using Prism software (GraphPad).

Selectivity in Native Mouse Proteome {#sec4.9}
------------------------------------

Mouse testis or brain cytosolic or membrane fractions were diluted to a total protein concentration of 2 mg mL^--1^. Proteome (19.5 μL) was incubated with DMSO (0.5 μL) or inhibitor (0.5 μL, 20 μM final concentration) for 30 min at 37 °C. Next, MB064 or TAMRA-FP (0.5 μL, 80 μM; 2 μM final concentration) was incubated for 15 min at 37 °C. The reactions were quenched with 10 μL standard 3×SDS PAGE sample buffer and analyzed as described above.

Chemoproteomic Selectivity Assay in Native Mouse Proteome {#sec4.10}
---------------------------------------------------------

Mouse testis or brain cytosolic or membrane fraction was diluted to a total protein concentration of 2 mg mL^--1^. 5 μL of 1 mM inhibitor (20 μM final concentration) or DMSO was added to 240 μL proteome and allowed to incubate for 30 min at 37 °C. FP-Biotin or MB108 (5 μL, 500 μM) was added and incubated for 30 min at 37 °C. The samples were further processed and analyzed as described previously.^[@ref16]^

Monoacylglycerol-Lipase ABHD2 Activity {#sec4.11}
--------------------------------------

Monoacylglycerol-lipase ABHD2 activity was assayed in transfected U2OS cell membrane (100,000*g* fraction; 100 μg for each point). Membranes were preincubated with serine protease/hydrolase inhibitor, MAFP (2.0 μM) (Cayman Chemicals, Ann Arbor, MI, U.S.A.) or **183** (5, 10, 20 μM), for 15 min at 37 °C. 2-Oleoyl-\[^3^H\]glycerol (10 μM, 10,000 cpm for each points (ARC, St. Louis, MO, U.S.A.)) was added and incubated for 30 min at 37 °C. The reaction was terminated by addition of a 2:1 (v/v) mixture of chloroform/methanol and centrifuged at 1600 rpm for 5 min, to induce phase separation. \[^3^H\]Glycerol release in the aqueous phase was measured by scintillation counting.

Acrosome Reaction {#sec4.12}
-----------------

In each experimental group, two C57BL/6NBD male mice were used. Spermatozoa were retrieved from epididymis and vas deferens, and were incubated in TYH solution under the reported experimental conditions.^[@ref35]^ Each assay was performed in triplicate.

Intracellular Calcium Levels {#sec4.13}
----------------------------

The spermatozoa were recovered from 6 mice epididymis and incubated at 37 °C, 5% CO~2~; stained with Fluo-3 AM; following a protocol by Bernabò et al.^[@ref36]^ under control (Ctrl) conditions or in the presence of the inhibitor (2 μM). After 30 min, P4 was added at the final concentration of 5 μM. As a positive control, both samples were added to Ionomycin 10 μM. The fluorescence was assessed every 5 min with a fluorimeter (Fluoroskan 96 well Reader, PerkinElmer). The data are expressed as Florescence Arbitrary Units and are the mean ± standard deviation of three independent samples.
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